Stock listing

XUP Stock Price, News, Filings & Events — Genfit Sa

Selected listing: XUP · GETTEX · EUR · DE

The XUP:GETTEX listing represents Genfit Sa, a biopharmaceutical company focused on developing innovative therapies for metabolic and liver diseases. Recently, the company has been active in advancing its clinical trials and has shared updates on its research initiatives. Investors can find relevant news, regulatory filings, and upcoming events that may impact the company's performance in the market. Genfit's strategic focus on addressing unmet medical needs positions it within a competitive landscape in the healthcare sector.

XUP:GETTEXEURDEUpdated July 24, 2026
Genfit Sa logo
Ticker
XUP:GETTEX
Asset type
Stock
Market cap
$757.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Genfit Sa XUP:GETTEX stock context

The XUP:GETTEX listing represents Genfit Sa, a biopharmaceutical company focused on developing innovative therapies for metabolic and liver diseases. Recently, the company has been active in advancing its clinical trials and has shared updates on its research initiatives. Investors can find relevant news, regulatory filings, and upcoming events that may impact the company's performance in the market. Genfit's strategic focus on addressing unmet medical needs positions it within a competitive landscape in the healthcare sector.

Research Genfit Sa

Alternate listings